Hello again Peter
Just a quick response to Dusk’s mail. Lenalidomide in itself has not been shown to induce secondary cancers more than any other treatment except when it was taken initially in combination with certain other drugs. Look up on internet Myeloma Beacon, “Revlimid and Secondary Cancers”. Below is a quote from the article.
“Revlimid (lenalidomide) did not appear to be associated with an inÂcreased risk of secondary cancers when administered together with dexamethasone or cyclophosphamide.”
Other recent international study results comparing dexamethasone and prednison are also available on Myeloma Beacon.
When diagnosed with MM 5 years ago I was prescribed lenalidomide, prednison and melphalan, the exact combination that is now known to give a 5x greater risk of secondary cancers. I don’t dwell on it but do keep alert.
Annette